Maci 3CM x 5CM implant sheets
Ended Awarded
- Contract number
- SPE2DB25FU7MU
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $61,539
Award facts
- Contract value 100% obligated
- $61,538.77 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $61,538.77 by the Defense Logistics Agency (DLA) on August 8, 2025. The delivery order, with an ultimate completion date of August 29, 2025, is for MACI 3cm x 5cm implant sheets—a regenerative medicine product used in cartilage repair and orthopedic applications. This award was issued without a set-aside designation, allowing the vendor to compete on an unrestricted basis. The contract represents a single delivery order under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with DLA, valued at $499,999,999 and valid through November 2026.
This delivery order is part of DMS Pharmaceutical Group's established role as a critical supplier within the federal pharmaceutical supply chain, providing specialized medical products and pharmaceutical supplies to Department of Defense healthcare facilities nationwide. The vendor's extensive portfolio of federal contracts demonstrates consistent success in securing awards across diverse pharmaceutical categories, from oncology treatments to medical devices and specialty medications. The placement of performance in Park Ridge, Illinois ensures domestic distribution capabilities, supporting the DLA's mission to supply military health facilities with essential medical products and supplies.
Quick answers
Who was awarded contract SPE2DB25FU7MU?
SPE2DB25FU7MU was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 8, 2025.
How much is contract SPE2DB25FU7MU worth?
The government has obligated $61,539 on SPE2DB25FU7MU.
Is contract SPE2DB25FU7MU an order under another contract?
Yes. SPE2DB25FU7MU is a delivery order under SPE2DB22D9101, an indefinite delivery contract.
Was contract SPE2DB25FU7MU competed?
The extent of competition for SPE2DB25FU7MU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award